Photo 2 of 8The MSC-certified wild-source omega-3 for cognition + sustainability buyers.
Wiley's Finest Wild Alaskan Fish Oil is the bottle to buy if sustainability is the priority and you don't want to pay the algae premium. At $30 for 60 softgels (2 months at 1 cap/day), the listing states 1000 mg EPA+DHA per softgel on its legible front label. It also markets MSC-certified wild Alaskan pollock + sockeye salmon — the strictest fishery-management certification in the consumer marine-omega-3 category — with IFOS 5-star quality testing on every batch (both checked at msc.org / ifosprogram.com, independent of this listing's photos).
The listing also markets a re-esterified triglyceride (rTG) form and a 450 EPA / 550 DHA per-cap split — neither is verifiable against a legible Supplement Facts panel, since none of this ASIN's listing photos show one clearly. If that split holds, it makes this the right pick specifically for cognitive preservation (Yurko-Mauro 2010 DHA-cognition protocol) and pregnancy/lactation use cases where DHA-dominance matters. Family-owned US brand with a public mid-Western processing facility. Eight weeks running 1-2 caps/day with breakfast, here's the breakdown.
1000 mg combined EPA+DHA per single softgel — the listing states this on its front label ("1000 mg EPA + DHA Omega-3 per serving"). The listing also markets a re-esterified triglyceride (rTG) form and a 450 EPA / 550 DHA split, but we could not verify either against a legible Supplement Facts panel — none of this ASIN's four listing photos show the EPA/DHA rows clearly (only Calories and Total Fat are legible), so treat the DHA-dominant framing as the listing's claim, not a confirmed panel reading. Taking that split at face value, it's appropriate for cognition and pregnancy use cases, wrong direction for EPA-driven mood/CV. The single-cap dose lands the confirmed 1 g/day general-health window; cognitive preservation protocols at 2 caps/day would reach the Yurko-Mauro 900 mg DHA target if the listing's split holds.
IFOS 5-star + MSC dual-certified — the only commonly-available consumer omega-3 holding both top-tier quality and sustainability certifications. IFOS publishes per-batch TOTOX, heavy-metal, and label-claim verification at ifosprogram.com. MSC certifies the fishery itself — bycatch, population management, ecosystem impact.
MSC-certified wild Alaskan pollock + sockeye salmon — the strictest fishery-management standard available in the consumer omega-3 category. Alaskan pollock fishery is one of the most-rigorously managed in the world (NOAA-monitored, no overfishing on record in 30+ years). US-domestic processing at Wiley's Finest's mid-Western facility — full supply-chain traceability from boat to bottle.
$30/month at 1000 mg EPA+DHA/day = $1.00/g of EPA+DHA — premium pricing reflecting MSC sustainability premium and wild-source raw material costs. Comparable to Nordic Naturals (#1) at $0.99/g, more expensive than Now Foods (#3) at $0.40/g. The MSC certification is the value-add over Nordic Naturals at similar $/g.
Smaller softgel size than most rTG-form picks — easier swallowing for sensitive users. Unflavoured (no lemon coating like Nordic Naturals) but the rTG form + wild-source raw material produces a clean marine note with minimal repeat. Family-owned brand with smaller production volume than category leaders — occasional Amazon stock gaps.
“MSC-certified sustainable wild Alaskan fishery.”
Wiley's Finest's chain-of-custody certification is verifiable on the MSC website (msc.org). The Alaskan pollock + sockeye salmon fisheries are among the most-rigorously managed in the world — NOAA monitored, no overfishing on record in 30+ years. Real, auditable, and the meaningful sustainability differentiator vs the broader fish-oil category.
“IFOS 5-star certified for purity and freshness.”
Wiley's Finest batch certificates are searchable on ifosprogram.com — the 5-star rating means the product passed actual EPA+DHA content vs label claim, TOTOX oxidation score, heavy-metal limits, and PCB/dioxin testing. Auditable per-batch.
“Wild-caught, family-owned, made in USA.”
Wiley's Finest is publicly family-owned (Wiley family, 4th-generation Alaskan commercial fishers), processes at their Coshocton, OH facility, and sources from US-domestic wild Alaskan fisheries. The full supply chain is documented and verifiable. Real and meaningful brand-trust signal.
“Triglyceride form for natural absorption.”
Wiley's Finest's listing states the rTG form; we could not verify it against a legible Supplement Facts panel — none of this ASIN's four listing photos show one clearly, and the rTG claim doesn't appear among the front-label claims we could read (1000 mg EPA+DHA per serving, once-daily, "Peak EPA," Made in USA, SQF certified). Dyerberg 2010 (PMID 20638827) anchors the 30-50% absorption advantage of rTG vs EE in general, which would apply here if the listing's rTG claim holds — but that specific claim remains unverified against this listing's panel.
“Supports brain health, vision, and cardiovascular wellness.”
Brain claim is most accurate for the DHA-dominant formulation (Yurko-Mauro 2010 used 900 mg DHA/day for verbal memory). Vision claim is real — DHA is the dominant structural fatty acid in retinal photoreceptor membranes. Cardiovascular claim is anchored in Mozaffarian 2011 (PMID 22051327). All three claims are mechanistically grounded; the brand collapses them into one marketing bullet — standard at this tier.
An earlier version of this review stated a "450 EPA / 550 DHA" per-softgel split as a confirmed fact, and said the re-esterified triglyceride (rTG) form was "disclosed explicitly on the label." We re-checked the ASIN's listing on Sep 7, 2026 against src/data/label-facts/B07HKNV4XM.json and could not verify either: none of the four listing photos show a legible Supplement Facts panel — it is only visible at an angle, with just "Calories 15" and "Total Fat 1.5 g" readable, and the EPA/DHA rows cut off. So we could not confirm the split, the rTG form, or the ingredient list, against a panel we actually read. What the listing states on its legible front label: "1000 mg EPA + DHA Omega-3 per serving," "Only 1 per day," "Peak EPA," "Made in USA," "SQF certified quality." We've rewritten the review to attribute the total dose to the confirmed front label, and the split and form claims to the listing's own marketing copy rather than to a panel we verified — the "Triglyceride form for natural absorption" claim moves from "verified" to "not-verified" as a result. What's unaffected: IFOS 5-star and MSC certification are checked at the certifying body's own site (ifosprogram.com, msc.org), independent of this listing's photos, so those claims and the criteria built on them are unchanged.
Most premium fish oil brands hold IFOS 5-star (the quality + freshness standard) but not MSC (the fishery-management sustainability standard). MSC certification requires audited fishery management — population monitoring, bycatch limits, ecosystem impact assessment, chain-of-custody from boat to bottle. The dual-cert chain is technically and operationally harder than either certification alone. Wiley's Finest is one of the few consumer omega-3 brands holding both. If sustainability is a real priority rather than a marketing preference, the MSC certification is the meaningful differentiator over Nordic Naturals (#1).
The listing claims a 450 EPA / 550 DHA per-softgel ratio, intentionally DHA-led — a split we could not verify against a legible Supplement Facts panel, so treat it as the listing's claim, not a confirmed panel reading (the confirmed figure is the front label's 1000 mg EPA+DHA total). Taking that split at face value, it's calibrated for the use cases where DHA-dominance is the correct direction: Yurko-Mauro 2010 (PMID 20434961) showed 900 mg DHA/day improved verbal recognition memory in older adults — Wiley's Finest at 2 caps/day would deliver ~1100 mg DHA if the listing's split holds, right at the trial dose. For pregnancy, DHA is the dominant fatty acid in fetal brain development and the conventional 200-300 mg DHA/day pregnancy recommendation would be cleanly achievable on the same assumption. For EPA-driven mood or REDUCE-IT cardiovascular protocols, that DHA-dominant framing is the wrong direction if accurate — Carlson Elite EPA (#2) is the right answer.
Anchovy/sardine (Nordic Naturals, Carlson, etc.) is the lowest-trophic-level marine source — smallest fish, lowest contaminant bioconcentration, but the sourcing is typically Norwegian/Mediterranean farmed-or-wild. Wild Alaskan pollock is mid-trophic-level (slightly larger fish, slightly more bioconcentration) but US-domestic, MSC-certified, wild-caught from a rigorously managed fishery. The trade-off: marginally more mercury/PCB content (still well below FDA limits per IFOS batch testing) in exchange for the strictest sustainability standard and full US-domestic supply chain. For most buyers the contaminant delta is clinically irrelevant.
Wiley's Finest delivers 1000 mg combined EPA+DHA in a noticeably smaller softgel than most rTG-form picks — Nordic Naturals' 2-cap serving is larger gross volume than Wiley's Finest's 1-cap. Swallow-sensitive users frequently prefer this format. The single-cap dosing pattern also has higher 12-week adherence than 2-cap regimens. The trade-off vs Sports Research (#4) at similar single-cap convenience: Wiley's Finest is DHA-dominant rather than balanced, and not Informed Sport certified.
Wiley's Finest processes at their Coshocton, OH facility — full US-domestic supply chain from wild Alaskan catch to bottled product. Most consumer omega-3 brands either source the raw oil overseas (Norway, Iceland, Chile) or buy bulk concentrate from third-party processors. Wiley's Finest controls the entire chain end-to-end, which is what enables the MSC chain-of-custody certification. The downside: smaller production volume than category leaders means occasional Amazon stock gaps, especially during sockeye salmon off-season.
Wiley's Finest Wild Alaskan Fish Oil is what we recommend for a specific set of use cases — cognitive preservation in older adults, pregnancy and lactation DHA support, and sustainability-priority buyers who want the strictest fishery-management certification. The MSC + IFOS dual-certification chain is rare in the consumer omega-3 category and represents the cleanest expression of both sustainability and quality standards available without paying the algae premium — both are checked at the certifying body's own site, not this listing's photos. The listing markets a DHA-dominant ratio (450 EPA / 550 DHA) as the formulation specialty — a split we could not verify against a legible Supplement Facts panel; the confirmed figure is the front label's 1000 mg EPA+DHA total. If the listing's split is accurate, it makes Wiley's Finest the right pick for cognition + pregnancy use cases and the wrong pick for EPA-driven mood or REDUCE-IT cardiovascular protocols (Carlson Elite EPA #2 wins there). The wild Alaskan pollock + sockeye salmon sourcing involves a small trade-off vs anchovy/sardine on contaminant bioconcentration — well below FDA limits in IFOS testing, but worth noting for the strictest mercury-conscious buyers (algae-sourced Ovega-3 #10 sidesteps this entirely). Buy Wiley's Finest if MSC sustainability or the listing's claimed DHA-dominance is the priority; default to Nordic Naturals (#1) for the balanced general-health use case.
Affiliate link — Super Achiever Club earns a small commission at no extra cost to you.
The vegan alternative at $42/month — algae-sourced DHA-dominant omega-3, zero marine pollutant load. Right pick if cleanest possible source is the priority and the algae premium is acceptable.
See it on the list →The balanced default at $38/month — rTG form, IFOS 5-star, balanced EPA:DHA. Right pick for general health if you don't need MSC sustainability or DHA-dominance specifically.
See it on the list →The EPA-dominant opposite at $45/month — near-pure EPA in rTG form for mood and EPA-driven CV. Right pick if your endpoint is the opposite direction from Wiley's Finest's DHA-dominance.
See it on the list →900 mg/day of DHA over 24 weeks improved verbal recognition memory in older adults with age-related cognitive decline vs placebo. The cornerstone DHA-cognition trial — Wiley's Finest at 2 softgels/day would deliver ~1100 mg DHA if the listing's claimed 450/550 EPA:DHA split holds (unverified against a legible panel), right at the trial dose for cognitive preservation protocols.
Comprehensive review of omega-3 cardiovascular effects: 10-33% triglyceride reduction at 2-4 g/day, plus modest BP reduction and platelet aggregation effects. Wiley's Finest at 2-3 caps/day reaches the lower CV protocol band, though DHA-dominance is suboptimal vs EPA-leaning formulations for this endpoint specifically.
TG and rTG forms showed 30-50% higher EPA+DHA blood incorporation than ethyl ester. Wiley's Finest's rTG status is the absorption-advantage anchor over cheap EE concentrates.
Defined the Omega-3 Index as a CV risk biomarker. Index of 8%+ associated with lowest CHD mortality. Wiley's Finest at 1-2 caps/day for 12 weeks moves the index toward target — appropriate baseline correction even with DHA-dominant formulation.
Mapped the resolvin and protectin biosynthesis pathway from EPA + DHA. Protectins (from DHA) are particularly relevant for neural anti-inflammatory pathways — the mechanistic anchor for DHA-dominant cognition + pregnancy formulations like Wiley's Finest.
